Dopamine in neurotoxicity and neuroprotection:: what do D2 receptors have to do with it?

被引:140
|
作者
Bozzi, Y
Borrelli, E [1 ]
机构
[1] ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France
[2] CNR, Ist Neurosci, I-56100 Pisa, Italy
关键词
D O I
10.1016/j.tins.2006.01.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Accurate control of dopamine levels and/or the resulting dopamine-receptor interaction is essential for brain function. Indeed, several human neurological and psychiatric disorders are characterized by dysfunctions of the dopaminergic system. Dopamine has been reported to exert either protective or toxic effects on neurons, yet it is unclear whether these effects are receptor-dependent and, if so, which dopamine receptor could be involved. The D-2 dopamine receptor occupies a privileged position because its signalling might be neuroprotective in human diseases, such as Parkinson's disease, ischaemia and epilepsy. Unravelling the role of D-2 receptors in neuronal death and survival might be central to understanding the mechanisms that underlie several neuropathologies.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 50 条
  • [1] Do levodopa and/or ropinirole induce an internalization of D1 and/or D2 dopamine receptors?
    Muriel, MP
    Orieux, G
    Hirsch, EC
    MOVEMENT DISORDERS, 2002, 17 : S55 - S55
  • [2] Mesoaccumbal Dopamine Heterogeneity: What Do Dopamine Firing and Release Have to Do with It?
    de Jong, Johannes W.
    Fraser, Kurt M.
    Lammel, Stephan
    ANNUAL REVIEW OF NEUROSCIENCE, 2022, 45 : 109 - 129
  • [3] DO POSTSYNAPTIC D2 DOPAMINE-RECEPTORS EXIST ON THE RAT RENAL VASCULAR BED
    BARTHELMEBS, M
    KRIEGER, JP
    GRIMA, M
    IMBS, JL
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1991, 84 (08): : 1211 - 1213
  • [4] DOPAMINE-RECEPTORS - WHICH D4 DO YOU HAVE
    IVERSEN, L
    NATURE, 1992, 358 (6382) : 109 - 109
  • [5] Neuroprotection -: what does it mean?: what means do we have?
    Ehrenreich, H
    Sirén, AL
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2001, 251 (04) : 149 - 151
  • [6] Neuroprotection – what does it mean? – what means do we have?
    Hannelore Ehrenreich
    Anna-Leena Sirén
    European Archives of Psychiatry and Clinical Neuroscience, 2001, 251 : 149 - 151
  • [7] Measuring dopamine D2 receptors
    Dagher, A
    AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (10): : 1708 - 1709
  • [8] Polymorphisms in dopamine receptors: what do they tell us?
    Wong, AHC
    Buckle, CE
    Van Tol, HHM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 410 (2-3) : 183 - 203
  • [9] Neuroprotection in schizophrenia -: What does it mean?: What means do we have?
    Ehrenreich, H
    Sirpén, AL
    RISK AND PROTECTIVE FACTORS IN SCHIZOPHRENIA: TOWARDS A CONCEPTUAL MODEL OF THE DISEASE PROCESS, 2002, : 257 - 262
  • [10] Do dopamine agonists provide neuroprotection?
    Yamamoto, M
    NEUROLOGY, 1998, 51 (02) : S10 - S12